The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-amino-5-(4-hydroxyphenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitrile ID: ALA5280676
Max Phase: Preclinical
Molecular Formula: C14H10N4O4
Molecular Weight: 298.26
Associated Items:
Names and Identifiers Canonical SMILES: N#CC1=C(N)Oc2[nH]c(=O)[nH]c(=O)c2C1c1ccc(O)cc1
Standard InChI: InChI=1S/C14H10N4O4/c15-5-8-9(6-1-3-7(19)4-2-6)10-12(20)17-14(21)18-13(10)22-11(8)16/h1-4,9,19H,16H2,(H2,17,18,20,21)
Standard InChI Key: ZZNVDDZGPIFNDE-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
1.0756 0.4158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0756 1.2407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3585 1.6501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3564 1.2373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3564 0.4142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3575 0.0013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3575 -0.8241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0727 -1.2370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7876 -0.8243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5026 -0.4115 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0727 -2.0628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7876 -2.4754 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3575 -2.4756 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3574 -2.0628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0726 -2.4756 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7877 -2.0628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5026 -2.4754 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7877 -1.2370 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0726 -0.8241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0726 0.0013 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3574 -1.2370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3585 2.4756 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
8 7 1 0
9 8 1 0
9 10 3 0
11 8 2 0
11 12 1 0
13 11 1 0
14 13 1 0
15 14 1 0
16 15 1 0
16 17 2 0
18 16 1 0
18 19 1 0
19 20 2 0
21 19 1 0
21 7 1 0
14 21 2 0
3 22 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 298.26Molecular Weight (Monoisotopic): 298.0702AlogP: -0.01#Rotatable Bonds: 1Polar Surface Area: 144.99Molecular Species: NEUTRALHBA: 6HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.35CX Basic pKa: 1.31CX LogP: 0.19CX LogD: 0.14Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.58Np Likeness Score: -0.77
References 1. Elattar KM, El-Khateeb AY, Hamed SE.. (2022) Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs., 13 (5.0): [PMID:35694689 ] [10.1039/d2md00076h ]